Search

everythinglearnresearchcommunity

for

Search:↓

People with alopecia areata have higher rates of mental health issues, autoimmune diseases, and infections.

PRP and cell therapies may help with hair loss, but more research is needed.

Special and immunohistochemical stains are not routinely needed for diagnosing hair disorders.

Recombinant human epidermal growth factor is versatile, effective, and safe for long-term skin and mucosal treatments.

Rare changes in the KRT82 gene are linked to a higher risk of Alopecia Areata.

Nonsteroid treatments for alopecia areata show promise but need more high-quality research.

Both dermatologists and patients in Japan agree that treatment success for alopecia areata is having 20% or less scalp hair loss.

Some alopecia treatments might help treat COVID-19, but more research is needed.

Ritlecitinib shows promise as a versatile treatment for various autoimmune and inflammatory diseases.

The review shows how to properly diagnose and treat the loss of eyebrow and eyelash hair.

iNOS contributes to hair loss in obese diabetic mice and blocking it may encourage hair growth.

Young HS patients often have other physical and mental health issues, and research on HS covers a wide range of topics including genetics, triggers, treatments, and the need for more data.

The document concludes that autoimmune skin disorders are treated with corticosteroids and immunosuppressive drugs.

Dermatologists often neglect hair disorders due to complexity and lack of clear treatments, impacting patient care and highlighting the need for better education and interest in this area.

The analysis aims to identify the most effective and safest treatments for alopecia areata.

Old drugs like finasteride and spironolactone are being successfully used for hair loss and skin conditions, and many other drugs show promise for new uses in dermatology.

Azathioprine may help treat severe alopecia areata, but more research is needed.

Children's hair loss can be caused by various factors and should be treated with appropriate, age-specific methods and psychological support.

Baricitinib improves quality of life and reduces anxiety and depression in severe alopecia areata patients with hair regrowth.

Current treatments for folliculitis decalvans include antibiotics, isotretinoin, and potential new therapies like botulinum toxin A and PRP.

Alopecia Areata significantly lowers quality of life and current treatments are inadequate, highlighting a need for better therapies and standardized treatment protocols.

Severe alopecia areata greatly impacts quality of life, mental health, and daily activities.

Alopecia areata severely impacts quality of life, mental health, and work productivity.

NX35growth™ effectively promotes hair growth and improves hair health.

Both treatments for alopecia areata showed similar modest effectiveness.

Robotic hair transplantation with AI offers more reliable, precise, and efficient hair restoration.

Japanese patients and physicians often disagree on the severity of Alopecia Areata and treatment satisfaction, needing better communication and treatments.

Bee pollen, green tea, essential oils, and various plant extracts improve skin and hair health.

The Middle East and Africa need better data, treatment consensus, and support for Alopecia Areata.

COVID-19 can cause skin problems and affect dermatology treatments, with recommendations for skin care and cautious use of certain drugs.